Abstract
The study examined the associations of anthropometric measures of obesity with high sensitivity C-reactive protein (hs-CRP) levels in Turkish immigrants with type 2 diabetes (T2D) living in the Netherlands. A total of 110 participants, physician-diagnosed with T2D, aged 30 years and older were recruited from multiple sources from The Hague, Netherlands. Serum hs-CRP levels were measured with immunoturbidimetric assay. Glycated hemoglobin (A1C) was determined by high-pressure liquid chromatography. Measures of obesity: body weight, body mass index (BMI), waist circumference (WC), hip circumference (HC), waist-to-hip ratio (WHR), and waist-to-height ratio (WHtR) were determined. Statistical analysis included descriptive statistics, Pearson’s correlations and multiple linear regressions (MLR) stratified by gender. Hs-CRP was log transformed to achieve normality. Subjects with hs-CRP levels >10 mg/L (n = 17) were excluded from the analysis. Females had a higher BMI (p = 0.007), HC (p < 0.001), and WHtR (p = 0.011) as compared to males. Conversely, males had a higher weight (p = 0.007), and WHR (p < 0.001) than females. MLR showed that after controlling for covariates, log hs-CRP was positively associated with BMI (B = 0.039, SE = 0.019, β = 0.287, p < 0.05), WC (B = 0.025, SE = 0.011, β = 0.332, p < 0.05) and WHtR (B = 4.015, SE = 1.464, β = 0.376, p < 0.01) in females only. Gender-specific associations between obesity measures and hs-CRP level need to be further investigated in the Turkish immigrant population. Hs-CRP assessment may be added as a standard of care for T2D treatment within this population.
Similar content being viewed by others
References
Al-Daghri, N. M., Al-Attas, O. S., Alokail, M. S., Alkharfy, K. M., Shaik, N. A., Draz, H. M., et al. (2010). Gender-specific associations between insulin resistance, hypertension, and markers of inflammation among adult Saudis with and without diabetes mellitus type 2. Advances in Medical Sciences, 55(2), 179–185.
Anty, R., Bekri, S., Luciani, N., Saint-Paul, M. C., Dahman, M., Iannelli, A., et al. (2006). The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, Type 2 diabetes, and NASH. American Journal of Gastroenterology, 101(8), 1824–1833.
Bouma, M., Rutten, G. E., de Grauw, W. J., Wiersma, T., & Goudswaard, A. N. (2006). Nederlands Huisartsen Genootschap. Summary of the practice guideline ‘Diabetes mellitus type 2’ (second revision) from the Dutch College of General Practitioners. [Article in Dutch]. Nederlands Tijdschrift voor Geneeskunde, 150(41), 2251–2256.
Browning, L. M., Hsieh, S. D., & Ashwell, M. (2010). A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0·5 could be a suitable global boundary value. Nutrition Research Reviews, 23(2), 247–269.
Caan, B., Armstrong, M. A., Selby, J. V., Sadler, M., Folsom, A. R., Jacobs, D., et al. (1994). Changes in measurements of body fat distribution accompanying weight change. International Journal of Obesity and Related Metabolic Disorders, 18(6), 397–404.
Can, A. S., Bersot, T. P., Gönen, M., Pekcan, G., Rakıcıoğlu, N., Samur, G., et al. (2009). Anthropometric indices and their relationship with cardiometabolic risk factors in a sample of Turkish adults. Public Health Nutrition, 12(4), 538–546.
Can, A. S., Yildiz, E. A., Samur, G., Rakicioğlu, N., Pekcan, G., Ozbayrakçi, S., et al. (2010). Optimal waist: height ratio cut-off point for cardiometabolic risk factors in Turkish adults. Public Health Nutrition, 13(4), 488–495.
Centersfor Disease Control and Prevention. (2002). Cigarette smoking among adults—United States, 2000. Morbidity and Mortality Weekly Report, 51, 642–645.
Centraal Bureau voor de Statistiek. Turkse ingezetenen in Nederland 2011. (2012) Retrieved from: http://statline.cbs.nl/StatWeb/publication/?VW=T&DM=SLNL&PA=37325&D1=0&D2=a&D3=0&D4=0&D5=2-4,11,38,46,95-96,137,152,173,177,194,215,232&D6=0,4,8,12,l&HD=100209-1037&HDR=T,G2,G3,G5&STB=G1,G4.
Chou, H. H., Hsu, L. A., Liu, C. J., Teng, M. S., Wu, S., & Ko, Y. L. (2010). Insulin resistance is associated with C-reactive protein independent of abdominal obesity in nondiabetic Taiwanese. Metabolism, 59(6), 824–830.
Connelly, P. W., Hanley, A. J., Harris, S. B., Hegele, R. A., & Zinman, B. (2003). Relation of waist circumference and glycemic status to C-reactive protein in the Sandy Lake Oji-Cree. International Journal of Obesity and Related Metabolic Disorders, 27(3), 347–354.
Consensus Committee. (2007). Consensus statement on the worldwide standardization of the hemoglobin A1C measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation. Diabetes Care, 30(9), 2399–2400.
de Koning, L., Merchant, A. T., Pogue, J., & Anand, S. S. (2007). Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. European Heart Journal, 28(7), 850–856.
Flores-Alfaro, E., Parra-Rojas, I., Salgado-Bernabé, A. B., Chávez-Maldonado, J. P., & Salazar-Martinez, E. (2008). Cardiovascular risk evaluated by C-reactive protein levels in diabetic and obese Mexican subjects. Circulation Journal, 72(7), 1170–1174.
Huffman, F. G., Gomez, G. P., & Zarini, G. G. (2009). Metabolic syndrome and high-sensitivity C-reactive protein in Cubans. Ethnicity & Disease, 19(2), 115–120.
Huffman, F. G., Whisner, S., Zarini, G. G., & Nath, S. (2010). Waist circumference and BMI in relation to serum high sensitivity C-reactive protein (hs-CRP) in Cuban Americans with and without type 2 diabetes. International Journal of Environmental Research and Public Health, 7(3), 842–852.
Kriegsman, D., van Langen, J., Valk, G., Stalman, W., & Boeke, J. (2003). Hoge prevalentie van diabetes mellitus type 2 bij Turken and Marokkanen. Huisarts & Wetenschap, 46(7), 363–368.
Lolekha, P. H., Chittamma, A., Roberts, W. L., Sritara, P., Cheepudomwit, S., & Suriyawongpaisal, P. (2005). Comparative study of two automated high-sensitivity C-reactive protein methods in a large population. Clinical Biochemistry, 38(1), 31–35.
Mojiminiyi, O. A., Al Mulla, F., & Abdella, N. A. (2009). Which obesity index best explains the link between adipokines, coronary heart disease risk and metabolic abnormalities in type 2 diabetes mellitus? Medical Principles and Practice, 18(2), 123–129.
Onat, A., Sansoy, V., Yildirim, B., Keleş, I., Uysal, O., & Hergenç, G. (2001). C-reactive protein and coronary heart disease in western Turkey. The American Journal of Cardiology, 88(6), 601–607.
Onat, A., Uyarel, H., Hergenç, G., Karabulut, A., Albayrak, S., & Can, G. (2007). Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study. Atherosclerosis, 191(1), 182–190.
Onat, A., Can, G., & Hergenç, G. (2008). Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk. Metabolism, 57(2), 207–214.
Onat, A., Can, G., Hergenç, G., Uğur, M., & Yüksel, H. (2011). Coronary disease risk prediction algorithm warranting incorporation of C-reactive protein in Turkish adults, manifesting sex difference. Nutrition, Metabolism, and Cardiovascular Diseases. doi:10.1016/j.numecd.2010.10.010.
Pai, J. K., Hankinson, S. E., Thadhani, R., Rifai, N., Pischon, T., & Rimm, E. B. (2006). Moderate alcohol consumption and lower levels of inflammatory markers in US men and women. Atherosclerosis, 186(1), 113–120.
Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., III, Criqui, M., et al. (2003). Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation, 107(3), 499–511.
Pickup, J. C. (2004). Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care, 27(3), 813–823.
Prasad, K. (2006). C-reactive protein (CRP)-lowering agents. Cardiovascular Drug Reviews, 24(1), 33–50.
Saltevo, J., Kautiainen, H., & Vanhala, M. (2009). Gender differences in adiponectin and low-grade inflammation among individuals with normal glucose tolerance, prediabetes, and type 2 diabetes. Gender Medicine, 6(3), 463–470.
Schneider, H. J., Glaesmer, H., Klotsche, J., Böhler, S., Lehnert, H., Zeiher, A. M., et al. (2007). Accuracy of anthropometric indicators of obesity to predict cardiovascular risk. Journal of Clinical Endocrinology and Metabolism, 92(2), 589–594.
Schneider, H. J., Friedrich, N., Klotsche, J., Pieper, L., Nauck, M., John, U., et al. (2010). The predictive value of different measures of obesity for incident cardiovascular events and mortality. Journal of Clinical Endocrinology and Metabolism, 95(4), 1777–1785.
Snijder, M. B., Dekker, J. M., Visser, M., Stehouwer, C. D., Yudkin, J. S., Bouter, L. M., et al. (2003). Prospective relation of C-reactive protein with type 2 diabetes: response to Han et al. Diabetes Care, 26(5), 1656–1657. author reply 1657–1658.
Soinio, M., Marniemi, J., Laakso, M., Lehto, S., & Rönnemaa, T. (2006). High-sensitivity C-reactive protein and coronary heart disease mortality in patients with type 2 diabetes: a 7-year follow-up study. Diabetes Care, 29(2), 329–333.
Thorand, B., Baumert, J., Döring, A., Schneider, A., Chambless, L., Löwel, H., et al. (2006). Association of cardiovascular risk factors with markers of endothelial dysfunction in middle-aged men and women. Results from the MONICA/KORA Augsburg Study. Journal of Thrombosis and Haemostasis, 95(1), 134–141.
Uitewaal, P. J., Goudswaard, A. N., Ubink-Veltmaat, L. J., Bruijnzeels, M. A., Hoes, A. W., & Thomas, S. (2004). Cardiovascular risk factors in Turkish immigrants with type 2 diabetes mellitus: comparison with Dutch patients. European Journal of Epidemiology, 19(10), 923–929.
Uitewaal, P. J., Manna, D. R., Bruijnzeels, M. A., Hoes, A. W., & Thomas, S. (2004). Prevalence of type 2 diabetes mellitus, other cardiovascular risk factors, and cardiovascular disease in Turkish and Moroccan immigrants in North West Europe: a systematic review. Preventive Medicine, 39(6), 1068–1076.
Ujcic-Voortman, J. K., Baan, C. A., Verhoeff, A. P., Krol, A., & Seidell, J. C. (2011). Ethnic differences in systemic inflammation: an investigation of C-reactive protein levels among Moroccan, Turkish and Dutch groups in the Netherlands. Atherosclerosis, 218(2), 511–516.
van Leest, L. A. T. M., van Dis, S. J. & Verschuren, W. M. M. (2002). Hart- en vaatziekten bij allochtonen in Nederland. Een cijfermatige verkenning naar leefstijl- en risicofactoren, ziekte en sterfte. RIVM Rapport Bilthoven (The Dutch National Institute for Public Health and the Environment).
Westerbacka, J., Cornér, A., Tiikkainen, M., Tamminen, M., Vehkavaara, S., Häkkinen, A. M., et al. (2004). Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk. Diabetologia, 47(8), 1360–1369.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sukhram, S.D., Zarini, G.G., Shaban, L.H. et al. Obesity and Serum High Sensitivity C-Reactive Protein Levels Among Elderly Turkish Immigrants in the Netherlands with Type 2 Diabetes. Ageing Int 39, 68–80 (2014). https://doi.org/10.1007/s12126-012-9149-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12126-012-9149-0